Managing joint pain in breast cancer survivors
Official title: Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors
Run by Memorial Sloan Kettering Cancer Center · NCT06728579 · Data updated 2026-11-12
This study tests whether two different group therapy approaches can help breast cancer survivors manage joint pain from their medication and improve their overall well-being.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 200 (estimated) |
| Sponsor | Memorial Sloan Kettering Cancer Center Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 9 sites (San Diego, California and 8 other locations) |
| Status | Recruiting |
| Started | December 6, 2024 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT06728579 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-proficient women aged 18 and older with a history of stage I, II, or III breast cancer who are experiencing joint pain related to aromatase inhibitor therapy.
✕Probably not a fit
Patients with metastatic breast cancer or those who have recently completed chemotherapy, surgery, or radiation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study compares two types of group therapy to help breast cancer survivors manage joint pain caused by aromatase inhibitors. Participants will engage in weekly 2-hour sessions over 8 weeks, focusing on either Mindfulness Oriented Recovery Enhancement or Supportive Psychotherapy. The study aims to assess the impact of these therapies on pain, fatigue, anxiety, and overall quality of life, as well as the participants' ability to continue their medication regimen. Data will be collected through questionnaires to evaluate the effectiveness of each approach.
Why it matters
Potential benefit: If successful, this study could provide effective coping strategies for managing joint pain, improving the quality of life for breast cancer survivors.
How similar studies have gone: Other studies have shown promise in using mindfulness and supportive therapies for pain management, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * English-proficient women with a history of stage I, II, or III breast cancer * Free of oncologic disease by clinical examination and history; * Receiving third-generation AI therapy (anastrozole, letrozole, or exemestane) for at least 28 days prior to consent with plan to continue for at least another 12 months; * Worst joint pain rated at least 4 or greater on a 0-10 numeric rating scale in the preceding week prior to consent; * Reporting at least 15 days with pain in the preceding 30 days prior to consent; * Experiencing joint pain for at least one month; * Pain attributed to AI therapy; * Willing to adhere to all study-related procedures, including randomization to one of two treatment arms: Mindfulness-Oriented Recovery Enhancement (MORE) or Supportive Group Psychotherapy (SG); * Able to attend video-call sessions in a quiet/private location. Exclusion Criteria: * Metastatic breast cancer (stage IV); * Completed chemotherapy, surgery, or radiation therapy less than 4 weeks prior to enrollment; * Pain attributed to inflammatory arthritis (i.e. rheumatoid arthritis, gout, pseudogout); * Surgery or joint injection involving the affected joints within the last month or planned within the next six months; * Active suicidality or psychosis as determined by the Mini-International Neuropsychiatric Interview.
Where it's running
-
University of California San Diego (Data collection and Data analysis)
San Diego, California, United States Recruiting -
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge, New Jersey, United States Recruiting -
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, New Jersey, United States Recruiting -
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale, New Jersey, United States Recruiting -
Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities)
Commack, New York, United States Recruiting -
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison, New York, United States Recruiting
Show 3 more locations
-
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, United States Recruiting -
Memorial Sloan Kettering Nassau (All Protocol Activities)
Uniondale, New York, United States Recruiting -
Florida State University
Tallahassee, Florida, United States Not yet recruiting
Study contacts
- Principal investigator: Jun Mao, MD, MSCE — Memorial Sloan Kettering Cancer Center
- Study coordinator: Jun Mao, MD, MSCE
- Email: maoj@mskcc.org
- Phone: 646-608-8553
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CRAFT-G: a remote group program to help brain function after breast cancer
A remotely delivered group program called CRAFT-G tests whether group cognitive retraining and functional strategies can help breast cancer survivors with cognitive symptoms feel and function better.
-
Virtual app to support breast and colorectal cancer survivors
This study will test whether a mobile app helps breast and colorectal cancer survivors after primary treatment manage follow-up care and find community and health-system resources.
-
Home-based tDCS for cognitive problems in breast cancer survivors with and without obesity
This will test whether home-based transcranial direct current stimulation (tDCS) can improve cancer-related memory, attention, or processing speed problems in breast cancer survivors and whether obesity changes the effect.
-
Combining motor imagery and watching action videos to improve upper‑limb function in female breast cancer survivors
This trial will test whether combining motor imagery with watching action videos can help improve arm strength, range of motion, pain, swelling, or fear of movement in women who have completed breast cancer treatment.
-
Moving on After Breast Cancer: support for breast cancer survivors with depression in Pakistan
This trial will test a three-stage adaptive program to see if it helps breast cancer survivors in Pakistan who have major depression feel better and lowers care costs.
-
Prolonged nightly fasting to improve sleep and cognition in breast cancer survivors
This study is testing if a nightly fasting plan can help breast cancer survivors improve their sleep, thinking skills, and overall well-being.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.